Literature DB >> 12816882

Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis.

Katharina Lötzer1, Rainer Spanbroek, Markus Hildner, Anja Urbach, Regine Heller, Ellen Bretschneider, Helen Galczenski, Jilly F Evans, Andreas J R Habenicht.   

Abstract

OBJECTIVE: Inflammatory infiltrates and atherosclerotic lesions emerge when monocytes adhere to endothelial cells (ECs), migrate into the subendothelial space, and become macrophages (MPhi(s)). Leukotrienes (LTs), products of 5-lipoxygenase, are powerful inflammatory mediators. 5-lipoxygenase+ MPhi(s) have been shown to increase during atherogenesis, and LT receptor (LT-R) transcripts were identified in diseased arteries. To investigate LT-Rs in cells involved in inflammation and atherogenesis, we used the in vitro models of human umbilical vein ECs (HUVECs) and monocyte-derived MPhi(s). METHODS AND
RESULTS: HUVECs primarily expressed transcripts of the cysteinyl (cys) LT2-R, which was strongly upregulated by interleukin-4. By contrast, MPhi(s) predominantly expressed transcripts of the cysLT1-R. Calcium responses toward LTs revealed differential cysLT-R utilization by both cell types: HUVECs responded to both cysLTs, whereas MPhi(s) preferentially responded to LTD4; HUVECs, but not MPhi(s), were resistant toward a cysLT1-R antagonist, montelukast; cysLTs generated regular calcium oscillations in HUVECs that lasted >60 minutes, resulting in >500 oscillations per cell. By contrast, calcium elevations in MPhi(s) returned to baseline within seconds and were nonoscillatory.
CONCLUSIONS: Our data raise the possibility that MPhi-derived LTs differentially activate cysLT2-Rs via paracrine stimulation and cysLT1-Rs via autocrine and paracrine stimulation during inflammation and atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12816882     DOI: 10.1161/01.ATV.0000082690.23131.CB

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  16 in total

1.  Leukotriene Inhibitors in Sinusitis.

Authors:  John W Steinke; Joshua L Kennedy
Journal:  Curr Infect Dis Rep       Date:  2012-01-29       Impact factor: 3.725

2.  Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-gamma on peripheral immune cells.

Authors:  S Brandon Early; Elizabeth Barekzi; Julie Negri; Kathleen Hise; Larry Borish; John W Steinke
Journal:  Am J Respir Cell Mol Biol       Date:  2007-02-01       Impact factor: 6.914

3.  Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.

Authors:  Yan Gong; Zhongjie Fu; Matthew L Edin; Chi-Hsiu Liu; Zhongxiao Wang; Zhuo Shao; Thomas W Fredrick; Nicholas J Saba; Peyton C Morss; Samuel B Burnim; Steven S Meng; Fred B Lih; Kin Sing Stephen Lee; Elizabeth P Moran; John Paul SanGiovanni; Ann Hellström; Bruce D Hammock; Darryl C Zeldin; Lois E H Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-14       Impact factor: 8.311

Review 4.  Intracranial arterial aneurysm vasculopathies: targeting the outer vessel wall.

Authors:  Timo Krings; Ronie L Piske; Pierre L Lasjaunias
Journal:  Neuroradiology       Date:  2005-09-01       Impact factor: 2.804

5.  CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors.

Authors:  Liaman Mamedova; Valérie Capra; Maria Rosa Accomazzo; Zhan-Guo Gao; Silvia Ferrario; Marta Fumagalli; Maria P Abbracchio; G Enrico Rovati; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2005-11-08       Impact factor: 5.858

6.  Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells.

Authors:  Barbara Uzonyi; Katharina Lötzer; Steffen Jahn; Cornelia Kramer; Markus Hildner; Ellen Bretschneider; Dörte Radke; Michael Beer; Rüdiger Vollandt; Jilly F Evans; Colin D Funk; Andreas J R Habenicht
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-10       Impact factor: 11.205

7.  The aneurysmal wall. The key to a subclassification of intracranial arterial aneurysm vasculopathies?

Authors:  T Krings; P L Lasjaunias; S Geibprasert; V Pereira; F J Hans
Journal:  Interv Neuroradiol       Date:  2008-10-09       Impact factor: 1.610

8.  Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury.

Authors:  Wei Jiang; Sean R Hall; Michael P W Moos; Richard Yang Cao; Satoshi Ishii; Kofo O Ogunyankin; Luis G Melo; Colin D Funk
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

Review 9.  Leukotriene signaling in atherosclerosis and ischemia.

Authors:  Magnus Bäck
Journal:  Cardiovasc Drugs Ther       Date:  2008-10-24       Impact factor: 3.727

10.  Cysteinyl leukotriene signaling through perinuclear CysLT(1) receptors on vascular smooth muscle cells transduces nuclear calcium signaling and alterations of gene expression.

Authors:  Alison Eaton; Edit Nagy; Mathilde Pacault; Jérémy Fauconnier; Magnus Bäck
Journal:  J Mol Med (Berl)       Date:  2012-04-20       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.